-- 切薩皮克黃金公司（Chesapeake Gold，股票代碼：CKG.V）週四宣布，其從硫化物礦石中提高金屬回收率的專有方法已獲得美國專利商標局頒發的美國專利。 該公司在美國、加拿大、阿根廷、澳洲、巴西、智利、墨西哥、秘魯和非洲均擁有已授權和正在申請的專利。 執行長讓-保羅·措措斯（Jean-Paul Tsotsos）表示：“這項專利支持了我們利用該技術為股東創造價值的企業戰略，釋放難開採硫化物金銀礦項目的經濟價值。” 該公司股票在多倫多證券交易所創業板（TSX Venture Exchange）的最新報收於3.38加元，下跌0.12加元。
Price: $3.38, Change: $-0.12, Percent Change: -3.43%
(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.
Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.
Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.